Bromocriptine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Bromocriptine and local guidelines before prescribing.
Dopamine agonist
Mechanism
Ergot-derived dopamine D2 agonist.
Uses
Hyperprolactinaemia, acromegaly, Parkinson disease.
Dosing
- Bromocriptine | PPCM (specialist): ESC regimen 2.5 mg once daily for 1 week (uncomplicated), or 2.5 mg twice daily for 2 weeks then once daily for 6 weeks (severe); always with at least prophylactic anticoagulation.
Cardiology: Cardiomyopathies - Bromocriptine Prolactinoma | Start 1–1.25 mg at bedtime, increase gradually; usual 2.5 mg two to three times daily. Nausea and postural hypotension.
Endocrinology: Pituitary Disease
Side effects
Nausea, postural hypotension, nasal congestion, psychiatric effects, pulmonary fibrosis.
Interactions
Antipsychotics antagonise; macrolides raise levels.
Contraindications and cautions
Severe cardiovascular disease, pre-eclampsia
Monitoring
Prolactin
Pregnancy and breastfeeding
Used for prolactinoma in pregnancy where needed
Renal and hepatic impairment
Caution in liver impairment
Overdose and reversal
Supportive
Special advice
Start low at night; fibrosis risk in long use.
More from the textbook: uses, cautions and other points
- Ergot-derived agonists (bromocriptine, cabergoline) cause heart valve and lung fibrosis - avoid, or monitor (echo).
Neurology: Movement Disorders - After delivery: Full HFrEF therapy (enalapril or captopril are compatible with breastfeeding); bromocriptine with prophylactic anticoagulation considered in specialist care.
Cardiology: Cardiomyopathies - A 31-year-old woman, 3 weeks postpartum and breastfeeding, is breathless with an LVEF of 28%. Answer: Peripartum cardiomyopathy - HFrEF therapy compatible with breastfeeding (e.g. enalapril, metoprolol), diuretics, consider bromocriptine with anticoagulation (stops lactation), wearable defibrillator, and counselling against further …
Cardiology: Cardiomyopathies - Ergot derivatives (cabergoline, bromocriptine) | Pleural and pulmonary fibrosis
Respiratory: Anatomy, Physiology and Pharmacology - Bromocriptine: An alternative, sometimes preferred when trying to conceive, because there is long safety experience in pregnancy.
Endocrinology: Pituitary Disease - Microprolactinoma: Stop cabergoline or bromocriptine once pregnancy is confirmed. The risk of significant growth is small (about 3%).
Endocrinology: Pituitary Disease - Neuroleptic malignant syndrome - dopamine blockade (antipsychotics) or sudden withdrawal of Parkinson's drugs : fever, rigidity ("lead pipe"), confusion, autonomic instability, very high CK; slower onset (days); stop the drug, cooling, fluids, ITU; dantrolene or bromocriptine in severe cases.
Neurology: Anatomy, Physiology and Pharmacology - Ergot agonists (bromocriptine, cabergoline) - fibrosis (heart valves, lungs) - rarely used now.
Neurology: Anatomy, Physiology and Pharmacology
Where it is discussed in the book
- Cardiology: Cardiomyopathies (3 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Endocrinology: Pituitary Disease (3 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (2 mentions)
- Neurology: Emergencies (1 mention)
- Neurology: Movement Disorders (1 mention)
- Obstetrics (1 mention)
- Gynaecology: Fertility Contraception Menopause (1 mention)
- Psychiatric emergencies (5 mentions)
- Emergency Medicine: Environmental emergencies (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Integrated cardiology chapter (3 mentions)